Decoy Therapeutics Inc.
DCOY
$2.99
$0.010.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 942.79% | 334.86% | 339.92% | 46.46% | -75.71% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 418.61% | 143.54% | -16.98% | -72.09% | -77.27% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 530.58% | 262.57% | 267.69% | 58.66% | -61.31% |
|
|
|||||
| Total Current Assets | 530.58% | 262.57% | 267.69% | 58.66% | -61.31% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -13.25% | -12.83% | -12.43% | -12.05% | -16.79% |
| Total Assets | 546.27% | 260.06% | 265.75% | 57.99% | -60.81% |
|
|
|||||
| Total Accounts Payable | -10.47% | -36.36% | 0.38% | 565.98% | 130.43% |
| Total Accrued Expenses | -70.87% | -64.80% | 143.87% | 69.31% | 38.33% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 110.59% | 99.60% | 241.94% | 97.84% | 88.59% |
|
|
|||||
| Total Current Liabilities | 110.59% | 99.60% | 241.94% | 97.84% | 88.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 110.59% | 99.60% | 241.94% | 97.84% | 88.59% |
|
|
|||||
| Common Stock & APIC | 23.40% | 20.13% | 20.25% | 7.59% | 2.32% |
| Retained Earnings | -17.08% | -15.58% | -15.28% | -6.22% | -6.42% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 620.78% | 6,163.97% | 289.56% | 45.25% | -134.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 620.78% | 6,163.97% | 289.56% | 45.25% | -134.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 620.78% | 6,163.97% | 289.56% | 45.25% | -134.93% |
|
|
|||||